CDC Logo Tuberculosis Information CD-ROM   Image of people
     
jump over main navigation bar to content area
Home
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Newsletters
Ordering Information
Help

 

U.S. Department of Health and Human Services

  

This is an archived document. The links are no longer being updated.

2005 Surveillance Slides

Completion of TB Therapy

United States, 1993–2003


Slide 26: Completion of TB Therapy, United States, 1993-2003
Slide 26. Completion of TB Therapy, United States, 1993–2003. The reporting areas began providing information on completion of therapy in 1993 through the individual TB case report form. The calculations exclude patients with an initial isolate resistant to rifampin as well as children with meningeal, bone or joint, or miliary disease. Overall completion of therapy has remained at approximately 92% from 1998 through 2003. Completion in 1 year or less increased from 64% in 1993 to approximately 80% in 1998—2003, the latest year with available data. The current DHHS Healthy People 2010 objective is completion of therapy in 1 year or less in 90% of patients. CDC is working with state and local health departments to determine and evaluate reasons for apparently delayed completion of therapy, which may vary by jurisdiction.

 


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination - http://www.cdc.gov/tb

Please send comments/suggestions/requests to: hsttbwebteam@cdc.gov, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333